top of page

Search Results

Results found for "opioid pharmacology"

  • Quantifying Receptor Selectivity in Modern Drug Discovery

    discovery teams from advancing compounds based on artifacts of expression systems rather than intrinsic pharmacology If the assay threshold is too high, real pharmacology becomes invisible. Whole-Cell Responses: A Historical Complication Historically, pharmacology relied on whole-cell or tissue Strategic Implications for Drug Hunters Quantifying receptor selectivity correctly does more than refine pharmacological Why Terry’s Corner Terry’s Pharmacology Corner delivers weekly lectures from Dr.

  • Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research

    British J Pharmacology 2007 , 152 (4), 429–448. https://doi.org/10.1038/sj.bjp.0707332 . (4) Barbazán Pharmacological Research 2021 , 174 , 105970. https://doi.org/10.1016/j.phrs.2021.105970 . (6) Miranda-Pastoriza

  • Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today

    Even perfect receptor pharmacology fails if target-site exposure is insufficient or transient . single methyl group— can redefine clinical outcomes PK is the backbone of reproducible, actionable pharmacology Why Terry’s Corner Terry’s Corner  delivers weekly pharmacology lectures from Dr. Terry Kenakin, monthly AMAs, and a growing on-demand library built around pharmacology's most important Designed for pharmacologists, medicinal chemists, and discovery leaders who refuse to rely on assumptions

  • Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism

    Yet, any pharmacologist who’s pushed beyond textbook theory knows: biology rarely plays fair. Schild analysis turns receptor pharmacology into detective work, spotlighting mechanistic fingerprints Modern pharmacology has powerful modeling software, yet Schild analysis remains the litmus test for mechanism Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr. Built for pharmacologists refining tools, discovery teams solving bottlenecks, and leaders seeking credible

  • Breaking the Myth of High and Low Affinity Sites

    Yet some assumptions still shaping pharmacology workflows haven’t evolved as fast as today’s science. Unlock “Rethinking Affinity” Now Only in Terry's Corner _____ #GPCR #BindingAffinity #Pharmacology

  • GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors

    Corner , our founder Yamina Berchiche works closely with organizations to help them navigate receptor pharmacology Push the boundaries  of receptor pharmacology and its real-world applications.   📚 Terry’s Corner — The Only On-Demand Pharmacology Hub with Dr. GPCR  community, you already know about Terry’s Corner  — our exclusive, on-demand pharmacology series where Terry Kenakin breaks down receptor pharmacology, functional selectivity, and ligand bias in a

  • New Tools, Smart Signals, and The Kenakin Brief

    Early Access and Updates    Terry’s Corner is launching soon with monthly courses, AMAs, and real-world pharmacology A MOR-positive allosteric modulator (BMS-986122) selectively enhances opioid signaling  through specific

  • From Pipettes to Platforms: The Evolution of GPCR Research

    What started as hand-built assays on ice has become integrated platforms for drug discovery, systems pharmacology

  • How GPCR Spatial Signaling Sparked a Scientific Journey

    From Cambridge to Leadership That early curiosity led her to pursue a PhD in Molecular Pharmacology at

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    Rethinking Affinity, A Critical Edge for Drug Hunters One of the most persistent misconceptions in pharmacology apparent affinity differences delays key milestones. 🗣️ “Thank you for bringing this (Principles of Pharmacology At Alkermes, Sokhom Pin built an in vitro pharmacology group from scratch—not just a lab, but a culture Weekly News : jobs, events, papers, industry updates Exclusive discounts on Terry’s Corner  digital pharmacology Access this week’s full Premium Edition here ➤ Hashtags: #GPCR #DrGPCR #BindingAffinity #Pharmacology

  • From Failed Experiments to Predictive GPCR Models

    With limited structural data but a growing pharmacological interest, GPCRs presented the perfect challenge Pharmacology, on the other hand, is often outsourced through collaborations with expert labs who specialize Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists Trainees must learn how to interpret assay data, understand pharmacological context, and communicate predictive modeling matures, its role will continue to expand, guiding ligand discovery, informing pharmacology

  • Why Opposing Processes Matter for Your Next GPCR Drug

    β-receptor partial agonists, showing how heart rate set-points under different anesthetics can flip observed pharmacology Subscribe today and get direct access to decades of pharmacology experience that turn complex systems Why Terry’s Corner Most pharmacology training freezes at equilibrium snapshots.

  • Curve Shifts Don’t Lie, But Your Eyes Might

    When Curves Shift Some of the most difficult calls in pharmacology happen when two curves look  slightly Is it a real pharmacological effect, or just noise? Here’s where the F-test  becomes indispensable. engagement opportunities  through AMAs and topic suggestions Practical insights  distilled from decades of pharmacology curvecomparison #ftest #assayvalidation #experimentaldesignstatistics #assayreproducibility #ANCOVA #pharmacology

  • How System-Level GPCR Thinking Prevents Discovery Failures

    If your work touches GPCR pharmacology, these insights aren’t optional—they’re essential. Career opportunities:  Senior/Principal Scientist—GPCR Pharmacology; Principal Scientist—In Vitro Pharmacology Terry’s Corner: GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures Discovery collapses Researchers, pharmacologists, biotech teams, and decision-makers who rely on accurate, efficient, interpretation-first

  • Dr. GPCR and Eurofins DiscoverX Join Forces to Accelerate GPCR Drug Discovery

    community by expanding access to validated, industry-standard GPCR assay platforms that enable rigorous pharmacological accelerate GPCR-targeted drug discovery by connecting scientists with proven assay platforms, deep pharmacological are trusted by leading pharmaceutical companies worldwide to generate high-quality, decision-enabling pharmacological

  • Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization

    Each week we highlight the decisions that move GPCR projects forward—from pharmacology essentials to Years of chemistry, photophysics, and pharmacology condensed into one breakthrough: pHSense , a reagent They translated a fundamental principle of chemistry into a usable platform for pharmacology—showing GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

  • The Truth About GPCR Product Launches: Years in the Making

    GPCR internalization isn’t just a trafficking readout—it’s pharmacology. s partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier (GPCR pharmacology

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    crisis and the crucial role of GPCR pharmacology. The opioid crisis is evolving with the dangerous combination of fentanyl and the veterinary sedative Learn how fentanyl slows inhalation via opioid receptors, while xylazine prolongs exhalation through Problem Solved:  Gain a deeper understanding of the pharmacological underpinnings of opioid overdose, Access this week’s full Premium Edition here ➤ What our members say 🗣️ “The best pharmacology teacher

  • New role of β-arrestins in MOR signaling

    With around 187 people dying every day from an opioid overdose in the U.S., combatting the opioid overdose , although the last one comes with pharmacological side effects such as breathing difficulties and addiction and dynorphins, and four opioid receptors (ORs): μ-opioid receptor (MOR), κ-opioid receptor (KOR), δ-opioid important pharmacological targets. A brief history of opiates, opioid peptides, and opioid receptors.

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    research position in GPCR biochemistry and biophysics and a research associate/scientist in in vitro pharmacology “The best pharmacology teacher (Dr. Also super-valuable for those of us learning how to teach pharmacology” — Dr. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

  • Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did

    refining assays, exploring signaling bias, and building a robust knowledge base in one of the most pharmacologically A Career Built on Consistency From CGRP receptor antagonists at BMS to opioid receptor research at Alkermes

  • Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors

    Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the Therefore, CAN1404 acts as a pharmacological chaperone and can rescue cell surface expression and function effects of genetic mutations on GPCR function and provide a proof of therapeutic principle for FSHR pharmacological

  • 📰 GPCR Weekly News, April 1 to 7, 2024

    et al., for their research on Intracellular pocket conformations, determine signaling through the μ opioid Samuel Hoare on Advanced data analysis for GPCR pharmacology, which will be held on Thursdays between , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Research Unit Postdoctoral Scholar – Synaptic physiology, optical imaging, substance use disorder, pharmacology Research Fellow Postdoctoral Fellow – Molecular Pharmacology of Feeding Behavior Join Dr.

  • 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024

    Celebrating Excellence:   Patrick Sexton  and Arthur Christopoulos  Named Among Top 1% of Scientists in Pharmacology novo antibodies look more like drugs  GPCR Events, Meetings, and Webinars December 10 - 12, 2024 | Pharmacology | BIO International Convention 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    pharmacologic activity measurement, mechanisms of action, and GPCR discovery strategies. The Principles of Pharmacology I & II BUNDLE is your golden ticket to mastering the field. Secure your spot today and elevate your pharmacology expertise! Lead Researcher   GPCR Activation and Signaling Profiling the proximal proteome of the activated μ-opioid GPCRs in Neuroscience Opposing GPCR signaling programs protein intake setpoint in Drosophila Kappa Opioid

  • GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...

    GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease GPCRs arguably represent the most effective current therapeutic targets for a plethora of diseases. GPCRs also possess a pivotal role in the regulation of the physiological balance between healthy and pathological conditions; thus, their importance in systems biology cannot be underestimated. The molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated changes in organismal tissue complexity and compartmentalization, thus enabling a nuanced GPCR-based capacity to interdict multiple disease pathomechanisms at a systemic level. GPCRs have been long considered as controllers of communication between tissues and cells. This communication involves the ligand-mediated control of cell surface receptors that then direct their stimuli to impact cell physiology. Given the tremendous success of GPCRs as therapeutic targets, considerable focus has been placed on the ability of these therapeutics to modulate diseases by acting at cell surface receptors. In the past decade, however, attention has focused upon how stable multiprotein GPCR superstructures, termed receptorsomes, both at the cell surface membrane and in the intracellular domain dictate and condition long-term GPCR activities associated with the regulation of protein expression patterns, cellular stress responses and DNA integrity management. The ability of these receptorsomes (often in the absence of typical cell surface ligands) to control complex cellular activities implicates them as key controllers of the functional balance between health and disease. A greater understanding of this function of GPCRs is likely to significantly augment our ability to further employ these proteins in a multitude of diseases. Read full article

  • The Perils and Guardrails of Modifying Signalling Proteins in Bioassays

    findings suggest that GPCR biosensors consisting of modified G proteins, which have been implemented in pharmacological In: Kenakin TP, editor A Pharmacology Primer (Sixth Edition). Trends in Pharmacological Sciences. 30.         The mass action equation in pharmacology. Br J Clin Pharmacol. 2016;81(1):41-51. 32.         Quantitative approaches for studying G protein-coupled receptor signalling and pharmacology.

  • 📰 GPCR Weekly News, May 22 to 28, 2023

    GPCRs in Cardiology, Endocrinology, and Taste Pathophysiology and pharmacology of G protein-coupled receptors Your body naturally produces opioids without causing addiction or overdose – studying how this process works could help reduce the side effects of opioid drugs GPCR Events, Meetings, and Webinars The Illuminating (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology

  • 📰 GPCR Weekly News, June 10 to 16, 2024

    behavioral reward, and susceptibility to relapse Alcohol consumption does not impact delta and kappa opioid , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs HIGHLIGHT Principal Scientist, In vitro pharmacology Senior Scientist - Receptor Pharmacology Postdoctoral Scientist Senior Research Associate/Associate Scientist, Protein Science Post-Doctoral Fellow—Pharmacology

  • Dr. GPCR University registration is now open! Secure your spot now!

    Calebiro, Michael Decker, et al. for their study on Design, Synthesis, and Characterization of New δ Opioid Reading Materials Access to the private group Certificate Explore: Key metrics for assessing ligand pharmacology fibrosis progression Methods & Updates in GPCR Research Design, Synthesis, and Characterization of New δ Opioid , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology

bottom of page